Acute Asthma Assessment and Management
Immediately assess severity using objective measures: obtain peak expiratory flow (PEF), respiratory rate, heart rate, and ability to speak in complete sentences, then initiate treatment with nebulized albuterol 5 mg and systemic corticosteroids based on severity classification.
Initial Assessment - Classify Severity
Perform rapid clinical evaluation looking for these specific features:
Severe Asthma Features 1:
- Cannot complete sentences in one breath
- Pulse >110 beats/min
- Respirations >25 breaths/min
- PEF <50% of predicted or personal best
- Silent chest, cyanosis, or feeble respiratory effort
- Exhaustion, confusion, or altered consciousness
Life-Threatening Features 1:
- PEF <33% of predicted or best
- Silent chest, cyanosis, or feeble respiratory effort
- Bradycardia or hypotension
- Exhaustion, confusion, or coma
- Oxygen saturation <92% despite oxygen therapy
Moderate Features 1:
- Can speak in phrases but not complete sentences
- Pulse <110 beats/min
- Respirations <25 breaths/min
- PEF 50-75% of predicted or best
Immediate Treatment Protocol
For Severe or Life-Threatening Asthma 1:
Start immediately, do not delay:
- Oxygen 40-60% (CO2 retention is not aggravated by oxygen in asthma)
- Nebulized albuterol 5 mg (or terbutaline 10 mg) via oxygen-driven nebulizer 2
- Prednisolone 30-60 mg orally OR IV hydrocortisone 200 mg 1
- Add ipratropium 0.5 mg to nebulizer for severe/life-threatening cases 1
Reassess at 15-30 minutes after nebulizer treatment 1
If Life-Threatening Features Present 1:
- Add IV aminophylline 250 mg over 20 minutes (do NOT give if patient already taking oral theophyllines)
- Consider IV salbutamol or terbutaline 250 µg over 10 minutes as alternative
- Arrange immediate ICU transfer if deteriorating
For Moderate Asthma 1:
- Nebulized albuterol 5 mg
- Prednisolone 30-60 mg orally
- Monitor response at 15-30 minutes
Post-Treatment Decision Algorithm
At 15-30 minutes after initial nebulizer 1:
If PEF >75% predicted/best:
- Step up usual maintenance treatment
- Discharge with 48-hour follow-up
- Provide written self-management plan
If PEF 50-75% predicted/best:
- Repeat nebulized albuterol
- Give prednisolone 30-60 mg if not already given
- Observe minimum 60 minutes
- Reassess before discharge decision
If PEF <50% or any severe features persist:
- Arrange hospital admission immediately 1
- Continue oxygen and steroids
- Repeat nebulized albuterol more frequently (up to every 15-30 minutes)
- Add ipratropium 0.5 mg to nebulizer, repeat 6-hourly 1
Critical Admission Criteria 1, 3
Admit if ANY of the following:
- Any life-threatening features present
- PEF <33% after initial treatment
- Features of acute severe asthma persist after initial treatment
- More than one severe feature present
Lower threshold for admission if 3:
- Attack occurring in afternoon/evening
- Recent hospital admission or previous severe attacks
- Recent nocturnal symptoms
- Patient unable to assess own condition
- Poor social circumstances
Discharge Criteria and Management
Only discharge if ALL criteria met 1:
- PEF >75% of predicted or best
- Stable for at least 1 hour after last albuterol dose
- Patient observed minimum 60 minutes (mild) to 2 hours (moderate)
Mandatory discharge prescriptions 1, 4:
- Prednisolone 30-60 mg daily for 7-14 days (no taper needed) 4
- Inhaled corticosteroids in addition to bronchodilators 3
- Ensure adequate supply of albuterol 2
- Provide peak flow meter and written self-management plan
- Verify correct inhaler technique before discharge
- Primary care review within 48 hours
- Respiratory clinic appointment within 4 weeks
Common Pitfalls to Avoid
Critical errors that increase mortality 1:
- Failing to assess severity objectively with PEF measurement
- Underusing systemic corticosteroids
- Discharging patients too early without adequate observation
- Not providing oral corticosteroids at discharge
- Failing to arrange timely follow-up
Important cautions 2:
- Do not use sedatives of any kind in acute asthma 1
- Albuterol may cause hypokalemia with repeated dosing (usually asymptomatic) 2
- If patient already using albuterol frequently at home and presents with worsening symptoms, this indicates seriously deteriorating asthma requiring aggressive treatment 2
Note on nebulizer dosing: The standard adult dose is 2.5 mg (one 3 mL vial of 0.083% solution) administered 3-4 times daily in stable asthma 2, but in acute exacerbations, dosing frequency increases to every 15-30 minutes as needed based on response 1.